These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19287907)

  • 21. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.
    Retnakaran R; Shen S; Hanley AJ; Vuksan V; Hamilton JK; Zinman B
    Obesity (Silver Spring); 2008 Aug; 16(8):1901-7. PubMed ID: 18551118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk assessment by post-challenge plasma glucose, insulin response ratio, and other indices of insulin resistance and/or secretion for predicting the development of type 2 diabetes.
    Tanabe N; Saito K; Yamada Y; Takasawa T; Seki N; Suzuki H
    Intern Med; 2009; 48(6):401-9. PubMed ID: 19293537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of disturbed glucose metabolism and surrogate measures of insulin sensitivity in obese children and adolescents.
    Roth CL; Elfers C; Hampe CS
    Nutr Diabetes; 2017 Dec; 7(12):301. PubMed ID: 29242622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL.
    Nyirjesy SC; Sheikh S; Hadjiliadis D; De Leon DD; Peleckis AJ; Eiel JN; Kubrak C; Stefanovski D; Rubenstein RC; Rickels MR; Kelly A
    Pediatr Diabetes; 2018 Nov; 19(7):1173-1182. PubMed ID: 29885044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between insulin resistance and β-cell dysfunction in subphenotypes of prediabetes and type 2 diabetes.
    Færch K; Johansen NB; Witte DR; Lauritzen T; Jørgensen ME; Vistisen D
    J Clin Endocrinol Metab; 2015 Feb; 100(2):707-16. PubMed ID: 25387263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between cardiorespiratory fitness and the determinants of glycemic control across the entire glucose tolerance continuum.
    Solomon TP; Malin SK; Karstoft K; Knudsen SH; Haus JM; Laye MJ; Kirwan JP
    Diabetes Care; 2015 May; 38(5):921-9. PubMed ID: 25784661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
    Meneilly GS; Elliott T
    Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study.
    Ohn JH; Kwak SH; Cho YM; Lim S; Jang HC; Park KS; Cho NH
    Lancet Diabetes Endocrinol; 2016 Jan; 4(1):27-34. PubMed ID: 26577716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.
    Mari A; Manco M; Guidone C; Nanni G; Castagneto M; Mingrone G; Ferrannini E
    Diabetologia; 2006 Sep; 49(9):2136-43. PubMed ID: 16819611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA; Omar MA; Gouws E
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
    Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
    Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
    Song DK; Hong YS; Sung YA; Lee H
    PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Each degree of glucose intolerance in pregnancy predicts distinct trajectories of β-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum.
    Kramer CK; Swaminathan B; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
    Diabetes Care; 2014 Dec; 37(12):3262-9. PubMed ID: 25231898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of fasting and post-load glucose homeostasis are largely independent and sustained by distinct and early major beta-cell function defects: a cross-sectional and longitudinal analysis of the Relationship between Insulin Sensitivity and Cardiovascular risk (RISC) study cohort.
    Mengozzi A; Tricò D; Nesti L; Petrie J; Højlund K; Mitrakou A; Krebs M; Mari A; Natali A;
    Metabolism; 2020 Apr; 105():154185. PubMed ID: 32061908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding the clinical use of standard OGTT: the percentage increment of 2 h with respect to fasting glucose as an index of β-cell dysfunction.
    Carnevale Schianca GP; Mella R; Scaglia E; Bigliocca M; Colli E; Fra GP; Bartoli E
    Diabetes Metab Res Rev; 2011 Mar; 27(3):262-8. PubMed ID: 21309049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.